Overview
- 2 inspections across 2 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-03-31.
At a glance
Inspections
2
Sites
2
Observations
3
Career since
Jun 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novitium Pharma LLC | 31 Mar 2023 | Human Drugs | |
| CoreRX Inc. | 21 Jun 2019 | Human Drugs | View 483 → |
Sites inspected
Novitium Pharma LLCEast Windsor, United States1 insp.
CoreRX Inc.Clearwater, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Naveen B Kanthamneni's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site